Document is current
Any future updates will be listed below
-
Authors
Kawai, Toshinao https://orcid.org/0000-0002-4152-9301
Kanegane, Hirokazu https://orcid.org/0000-0002-8696-9378
Ishimura, Masataka https://orcid.org/0000-0002-0735-6566
Okada, Satoshi https://orcid.org/0000-0002-4622-5657
Okamatsu, Nobuaki
Nakagawa, Kaori
Go, Madoka
Noto, Shinichi https://orcid.org/0000-0002-6952-7770
-
Funding
Funding for this research was provided by:
Takeda Pharmaceutical Company
- License Information
-
More Information
Article History
Received: 13 June 2024
Accepted: 1 February 2025
First Online: 7 May 2025
Declarations
:
: The study was performed in line with the principles of the Declaration of Helsinki. Approval of the protocol, informed consent form, and study questionnaires was granted by the Ethics Committee of the Japan Conference of Clinical Research, and the study was registered at the University hospital Medical Information Network clinical trials registry (ID: UMIN000045622).
: Written informed consent was provided online by all participants or their legal representative.
: Not applicable.
: T.K. and H.K. have received honoraria from Takeda Pharmaceutical Company Limited. N.O., K.N., and M.G. are employees and minor shareholders of Takeda Pharmaceutical Company Limited. S.N. has received consulting fees from Takeda Pharmaceutical Company Limited. M.I. and S.O. have no competing interests to declare.
